P53 codon 72 Arg/Pro polymorphism and lung cancer risk in Asians: an updated meta-analysis
暂无分享,去创建一个
Y. Li | Siwen Wang | Siyang Wang | Sheng Tan | Xin-gang Lan
[1] D. Planchard,et al. Lung cancer in never-smokers , 2015, European Respiratory Journal.
[2] Hua-Fu Zhou,et al. Association of glutathione S-transferase P1 gene polymorphism with the susceptibility of lung cancer , 2012, Molecular Biology Reports.
[3] X. Xiao,et al. MMP1-1607 1G/2G polymorphism and lung cancer risk: a meta-analysis , 2012, Tumor Biology.
[4] S. Lei,et al. An updated meta-analysis of the p53 codon 72 polymorphism and gastric cancer risk , 2012, Molecular Biology Reports.
[5] H. Yu,et al. TP53 Codon 72 Polymorphism with Hepatocellular Carcinoma: A Meta-Analysis , 2012, The Journal of international medical research.
[6] A. Aboussekhra,et al. The p53 codon 72 polymorphism is associated with risk and early onset of breast cancer among Saudi women. , 2012, Oncology letters.
[7] Wei-Min Zhang,et al. Effect of CYP1A1 MSPI polymorphism on the relationship between TP53 mutation and CDKN2A hypermethylation in non-small cell lung cancer. , 2011, Archives of medical research.
[8] F. Fang,et al. Meta-analysis of the relationship between p21 Ser31Arg polymorphism and lung cancer susceptibility. , 2011, Genetics and molecular research : GMR.
[9] C. Dresler,et al. Epidemiology of lung cancer: smoking, secondhand smoke, and genetics. , 2011, Surgical oncology clinics of North America.
[10] Q. Wei,et al. Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck , 2011, Molecular carcinogenesis.
[11] Min-Ho Shin,et al. p53 codon 72 polymorphism and the risk of lung cancer in a Korean population. , 2011, Lung cancer.
[12] B. Ring,et al. Putative EPHX1 Enzyme Activity Is Related with Risk of Lung and Upper Aerodigestive Tract Cancers: A Comprehensive Meta-Analysis , 2011, PloS one.
[13] K. Sabapathy,et al. Effect of MDM2 SNP309 and p53 codon 72 polymorphisms on lung cancer risk and survival among non-smoking Chinese women in Singapore , 2010, BMC Cancer.
[14] Yong Song,et al. A meta-analysis of TP53 codon 72 polymorphism and lung cancer risk: evidence from 15,857 subjects. , 2009, Lung cancer.
[15] C. Mao,et al. P53 polymorphism and lung cancer susceptibility: a pooled analysis of 32 case–control studies , 2009, Human Genetics.
[16] H. Shin,et al. Association study of TP53 polymorphisms with lung cancer in a Korean population , 2008, Journal of Human Genetics.
[17] Y. Nakanishi,et al. EPHX1 Polymorphisms and the Risk of Lung Cancer: A HuGE Review , 2006, Epidemiology.
[18] Wen Tan,et al. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer , 2006, Human mutation.
[19] J. Yokota,et al. Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk , 2005, International journal of cancer.
[20] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[21] D. Wen,et al. [p53 gene polymorphism with susceptibility to esophageal cancer and lung cancer in Chinese population]. , 2003, Zhonghua zhong liu za zhi [Chinese journal of oncology].
[22] Ammarin Thakkinstian,et al. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. , 2003, Journal of clinical epidemiology.
[23] Hidemi Ito,et al. Different risk relations with smoking for non-small-cell lung cancer: comparison of TP53 and TP73 genotypes. , 2003, Asian Pacific journal of cancer prevention : APJCP.
[24] D. Christiani,et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[25] L. Le Marchand,et al. Relationships of TP53 codon 72 and HRAS1 polymorphisms with lung cancer risk in an ethnically diverse population. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[26] S. Rodin,et al. Human lung cancer and p53: the interplay between mutagenesis and selection. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[27] Miranda Thomas,et al. Two Polymorphic Variants of Wild-Type p53 Differ Biochemically and Biologically , 1999, Molecular and Cellular Biology.
[28] J P Vandenbroucke,et al. Bias in meta-analysis detected by a simple, graphical test , 1998 .
[29] G. Smith,et al. Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.
[30] A. Levine. p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.
[31] M. Tagawa,et al. Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history. , 1996, Carcinogenesis.
[32] R. Birgander,et al. p53 polymorphisms and haplotypes in different ethnic groups. , 1995, Human heredity.
[33] G. Matlashewski,et al. Molecular analysis of different allelic variants of wild-type human p53. , 1992, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[34] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[35] W. Haenszel,et al. Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.
[36] W. G. Cochran. The comparison of percentages in matched samples. , 1950, Biometrika.
[37] Qiushi Wang,et al. Association between p53 codon 72 genetic polymorphisms and tobacco use and lung cancer risk in a Chinese population , 2012, Molecular Biology Reports.
[38] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[39] Yiming Wu. Effects of p53 Arg/Pro gene polymorphism and smoking on the occurrence of lung cancer in Henan Han population , 2010 .
[40] G. Shao,et al. Association of polymorphism in TP53 gene with susceptibility and radiation sensitivity of non-small-cell-lung cancer in Chinese population , 2005 .
[41] P. Hainaut,et al. TP53 and mutations in human cancer. , 2003, Acta biochimica Polonica.
[42] P. Lin,et al. p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[43] L. Rubenstein,et al. Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. , 1998, BMJ.